[Elsevier] Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial

ThatFunnyFeelin Post time Yesterday 23:31 | Show all posts |Read mode
This post will be closed automatically in 2026-09-05 23:27
Reward30points


Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial


https://doi.org/10.1016/S2468-1253(25)00322-X
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    0


Return to the list